X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (474) 474
Publication (83) 83
Patent (25) 25
Book Chapter (3) 3
Book / eBook (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (251) 251
female (232) 232
oncology (184) 184
middle aged (178) 178
breast cancer (130) 130
index medicus (111) 111
breast neoplasms - drug therapy (109) 109
aged (106) 106
breast neoplasms - pathology (103) 103
adult (91) 91
chemotherapy (89) 89
antineoplastic combined chemotherapy protocols - therapeutic use (88) 88
chemotherapy, adjuvant (80) 80
cancer (76) 76
disease-free survival (72) 72
breast neoplasms - surgery (68) 68
treatment outcome (61) 61
tamoxifen (58) 58
neoplasm staging (57) 57
prognosis (57) 57
follow-up studies (55) 55
fluorouracil - administration & dosage (54) 54
tamoxifen - therapeutic use (54) 54
clinical trials (53) 53
male (53) 53
lymphatic metastasis (52) 52
surgery (52) 52
therapy (50) 50
breast neoplasms - mortality (47) 47
article (45) 45
combined modality therapy (42) 42
survival analysis (41) 41
cyclophosphamide - administration & dosage (39) 39
mastectomy (37) 37
surgical adjuvant breast (36) 36
doxorubicin - administration & dosage (35) 35
research (35) 35
risk factors (35) 35
antineoplastic combined chemotherapy protocols - adverse effects (33) 33
care and treatment (33) 33
randomized controlled trials as topic (33) 33
survival (33) 33
fluorouracil (32) 32
radiotherapy (32) 32
medicine, general & internal (31) 31
risk (31) 31
women (31) 31
colonic neoplasms - pathology (30) 30
original reports (30) 30
antineoplastic agents, hormonal - therapeutic use (29) 29
breast neoplasms - radiotherapy (29) 29
colonic neoplasms - drug therapy (29) 29
clinical trials as topic (28) 28
tumors (27) 27
carcinoma (26) 26
radiation-therapy (26) 26
adjuvant treatment (25) 25
human necessities (25) 25
hygiene (25) 25
mastectomy, segmental (25) 25
medical or veterinary science (25) 25
time factors (25) 25
leucovorin - administration & dosage (24) 24
proportional hazards models (24) 24
survival rate (24) 24
breast neoplasms - prevention & control (23) 23
breast neoplasms - metabolism (22) 22
breast neoplasms - therapy (22) 22
cancer therapies (22) 22
drug therapy (22) 22
health aspects (22) 22
neoplasm recurrence, local (22) 22
prospective studies (22) 22
tamoxifen - administration & dosage (22) 22
patient outcomes (21) 21
risk assessment (21) 21
trial (21) 21
diagnosis (20) 20
quality of life (20) 20
recurrence (20) 20
trastuzumab (20) 20
antineoplastic combined chemotherapy protocols - administration & dosage (19) 19
lymph nodes - pathology (19) 19
medicine & public health (19) 19
random allocation (19) 19
abridged index medicus (18) 18
breast (18) 18
leucovorin (18) 18
lumpectomy (18) 18
postmenopausal women (18) 18
randomized-trial (18) 18
aged, 80 and over (17) 17
breast neoplasms - chemistry (17) 17
colonic neoplasms - mortality (17) 17
colorectal cancer (17) 17
evaluation (17) 17
incidence (17) 17
neoplasm invasiveness (17) 17
prevention (17) 17
receptors, estrogen - analysis (17) 17
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (503) 503
French (10) 10
Spanish (4) 4
German (3) 3
Chinese (2) 2
Arabic (1) 1
Czech (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA surgery, ISSN 2168-6254, 01/2020, p. e195410
Neoadjuvant systemic therapy (NST) is often administered to enable breast-conserving therapy (BCT) in stages II to III breast cancer. To prospectively evaluate... 
Journal Article
Oncology Times, ISSN 0276-2234, 12/2019, Volume 41, Issue 24, pp. 1 - 6
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2019, p. JCO.19.01455
PURPOSE Adjuvant trastuzumab reduces invasive breast cancer (IBC) recurrence and risk for death in patients with HER2-amplified or overexpressing IBC. A subset... 
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12/2019, p. JCO1901455
Adjuvant trastuzumab reduces invasive breast cancer (IBC) recurrence and risk for death in patients with HER2-amplified or overexpressing IBC. A subset of... 
Journal Article
Breast cancer research : BCR, ISSN 1465-542X, 12/2019, Volume 21, Issue 1, pp. 133 - 11
The primary aim of NSABP FB-7 was to determine the pathologic complete response (pCR) rate in locally advanced HER2-positive (HER2 ) breast cancer patients... 
Neoadjuvant | Neratinib | Breast cancer
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2019, Volume 178, Issue 2, pp. 389 - 399
NSABP B-41, a phase three randomized trial, evaluated neoadjuvant lapatinib, trastuzumab, or the combination with chemotherapy in patients with HER2-positive... 
HER2 enriched | Medicine & Public Health | Intrinsic subtype | Oncology | Neoadjuvant | Breast cancer | Genomic | Trastuzumab | Medical research | Chemotherapy | Prognosis | Analysis | Medicine, Experimental | Gene expression | Cancer
Journal Article
Journal Article
JNCI: Journal of the National Cancer Institute, ISSN 0027-8874, 08/2019, Volume 111, Issue 8, pp. 867 - 871
Abstract We retrospectively assessed association of stromal tumor-infiltrating lymphocytes (sTILs) with clinical outcomes and molecular variables reportedly... 
PLACEBO | PIK3CA MUTATIONS | ONCOLOGY | TRASTUZUMAB BENEFIT | SUBTYPES | PHASE-III | PERTUZUMAB | DOCETAXEL | CHEMOTHERAPY | PATHOLOGICAL COMPLETE RESPONSE
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 511 - 511
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. TPS3620 - TPS3620
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.